KRAS and pancreatic neoplasm: Genomic analysis of pancreatic cancers identified core drivers including KRAS, TP53, SMAD4, and CDKN2A mutations as well as copy number variations including amplifications of MET and NOTCH1 (Waddell et al, 2015; Bailey et al, 2016).